Literature DB >> 6759216

Experimental chemical diabetes and pregnancy in the rat. Evolution of glucose tolerance and insulin response.

N Triadou, B Portha, L Picon, G Rosselin.   

Abstract

The effect of pregnancy on the course of experimental chemical diabetes (CD) has been studied in the rat. Glucose tolerance tests (0.5 g/kg i.v.) have been performed serially in the virgin state (2 mo), late pregnancy (20.5 day of gestation), and 1 and 2 mo after delivery, in control and in CD female rats. During gestation in the controls basal plasma glucose is decreased, and plasma glucose levels after glucose load, and also lower than levels found in the virgin state. Glucose tolerance is not significantly affected. Nevertheless, glucose-induced insulin secretion in pregnant animals is increased compared with the virgin state. Glucose tolerance remains unchanged 1 and 2 mo postpartum, but insulin response to glucose becomes significantly lower than in the virgin state. In the pregnant CD rats basal plasma glucose is decreased, but plasma glucose levels after glucose load are similar to values found in the virgin state, thus suggesting decreased glucose tolerance. Glucose-induced insulin secretion is increased compared with the virgin state. Glucose tolerance remains deteriorated 1 and 2 mo postpartum, but insulin secretion is no longer significantly different. These findings indicate that in CD female rats glucose tolerance is and remains deteriorated by pregnancy, while in normal female rats it is and remains unchanged. Thus, despite increased insulin response to glucose during late gestation in the CD rats, the diabetogenicity of pregnancy is confirmed with this experimental model.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6759216     DOI: 10.2337/diab.31.1.75

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

1.  Impaired pancreatic beta cell function in the fetal GK rat. Impact of diabetic inheritance.

Authors:  P Serradas; M N Gangnerau; M H Giroix; C Saulnier; B Portha
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

2.  Repercussions of mild diabetes on pregnancy in Wistar rats and on the fetal development.

Authors:  Felipe H Saito; Débora C Damasceno; Wilma G Kempinas; Glilciane Morceli; Yuri K Sinzato; Kristin N Taylor; Marilza Vc Rudge
Journal:  Diabetol Metab Syndr       Date:  2010-04-23       Impact factor: 3.320

3.  Neonatally induced mild diabetes in rats and its effect on maternal, placental, and fetal parameters.

Authors:  Yuri Karen Sinzato; Gustavo Tadeu Volpato; Isabela Lovizutto Iessi; Aline Bueno; Iracema de Mattos Paranhos Calderon; Marilza Vieira Cunha Rudge; Débora Cristina Damasceno
Journal:  Exp Diabetes Res       Date:  2012-06-20

Review 4.  Early-life origins of type 2 diabetes: fetal programming of the beta-cell mass.

Authors:  Bernard Portha; Audrey Chavey; Jamileh Movassat
Journal:  Exp Diabetes Res       Date:  2011-10-24

5.  Animal models for clinical and gestational diabetes: maternal and fetal outcomes.

Authors:  Ana Ci Kiss; Paula Ho Lima; Yuri K Sinzato; Mariana Takaku; Marisa A Takeno; Marilza Vc Rudge; Débora C Damasceno
Journal:  Diabetol Metab Syndr       Date:  2009-10-19       Impact factor: 3.320

6.  Monosodium glutamate neonatal treatment induces cardiovascular autonomic function changes in rodents.

Authors:  Signorá Peres Konrad; Vera Farah; Bruno Rodrigues; Rogério Brandão Wichi; Ubiratan Fabres Machado; Heno Ferreira Lopes; Beatriz D'Agord Schaan; Kátia De Angelis; Maria Cláudia Irigoyen
Journal:  Clinics (Sao Paulo)       Date:  2012-10       Impact factor: 2.365

7.  Neonatally induced mild diabetes: influence on development, behavior and reproductive function of female Wistar rats.

Authors:  Ana Carolina Inhasz Kiss; Barbara Woodside; Yuri Karen Sinzato; Maria Martha Bernardi; Wilma De Grava Kempinas; Janete Aparecida Anselmo-Franci; Débora Cristina Damasceno
Journal:  Diabetol Metab Syndr       Date:  2013-10-16       Impact factor: 3.320

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.